These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17276749)

  • 21. Targeted treatments for symptom domains in child and adolescent autism.
    Hollander E; Phillips AT; Yeh CC
    Lancet; 2003 Aug; 362(9385):732-4. PubMed ID: 12957098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    Williams K; Brignell A; Randall M; Silove N; Hazell P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pharmacological approach to the autistic spectrum].
    Morant A; Mulas F; Hernández S
    Rev Neurol; 2002 Feb; 34 Suppl 1():S64-7. PubMed ID: 12447792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism.
    Kane MJ; Angoa-Peréz M; Briggs DI; Sykes CE; Francescutti DM; Rosenberg DR; Kuhn DM
    PLoS One; 2012; 7(11):e48975. PubMed ID: 23139830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a basis for novel pharmacotherapy of autism?
    Hunsinger DM; Nguyen T; Zebraski SE; Raffa RB
    Life Sci; 2000 Aug; 67(14):1667-82. PubMed ID: 11021352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.
    Mouti A; Reddihough D; Marraffa C; Hazell P; Wray J; Lee K; Kohn M
    Trials; 2014 Jun; 15():230. PubMed ID: 24934401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autism and trichotillomania in an adolescent boy.
    Masiran R
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30185454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopharmacology in autism.
    Tsai LY
    Psychosom Med; 1999; 61(5):651-65. PubMed ID: 10511014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine in autism.
    Posey DI; Litwiller M; Koburn A; McDougle CJ
    J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):111-2. PubMed ID: 9951204
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug fails to subdue repetitive behavior in children with autism spectrum disorders.
    Harv Ment Health Lett; 2009 Oct; 26(4):7. PubMed ID: 19904836
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].
    Fukuda T; Sugie H; Ito M; Sugie Y
    No To Hattatsu; 2001 Jul; 33(4):314-8. PubMed ID: 11494573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatments: In the waiting room.
    Eisenstein M
    Nature; 2012 Nov; 491(7422):S14-6. PubMed ID: 23136658
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
    Pehrson AL; Sanchez C
    Drug Des Devel Ther; 2015; 9():603-24. PubMed ID: 25653499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of neocortical development and maturation in autism: insight from valproic acid exposure and animal models of autism.
    Chomiak T; Hu B
    Neurotoxicol Teratol; 2013; 36():57-66. PubMed ID: 22967743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dystrophic serotonin axons in postmortem brains from young autism patients.
    Azmitia EC; Singh JS; Hou XP; Wegiel J
    Anat Rec (Hoboken); 2011 Oct; 294(10):1653-62. PubMed ID: 21901837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. fMRI tracks reductions in repetitive behaviors in autism: two case studies.
    Dichter GS; Sikich L; Mahorney S; Felder JN; Lam KS; Turner-Brown L; Bodfish J
    Neurocase; 2010 Aug; 16(4):307-16. PubMed ID: 20178033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action.
    Ghoneim OM; Ibrahim DA; El-Deeb IM; Lee SH; Booth RG
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6714-23. PubMed ID: 21982496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children.
    El Marroun H; White TJ; van der Knaap NJ; Homberg JR; Fernández G; Schoemaker NK; Jaddoe VW; Hofman A; Verhulst FC; Hudziak JJ; Stricker BH; Tiemeier H
    Br J Psychiatry; 2014 Aug; 205(2):95-102. PubMed ID: 25252317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.